IP Library › Assignment 019781/0225
Patent Assignment
Reel/Frame 019781/0225

Change of Name

Recorded: 2007-09-04 Pages: 7
Assignor
ALTANA PHARMA AG
Executed: 2007-06-14
Assignee
NYCOMED GMBH
BYK-GULDEN-STR. 2, 78467 KONSTANZ, GERMANY
Covered Properties (19)
Medicinal Product Package for Eradication Therapy
Patent: 6,988,619 →
Application: 10/297,257 →
Publication: US US20030136698A1
Ciclesonide Contained Pharmaceutical Composition for Application to Mucosa
Patent: 6,767,901 →
Application: 10/110,629 →
Synergistic Combination
Patent: 7,056,936 →
Application: 10/437,005 →
Publication: US US20040034087A1
Oral Administration Form for Pyridin-2-Ylmethylsulfinyl-1H-Benzimidazoles
Patent: 7,041,313 →
Application: 09/762,302 →
Phenylphennanthridines with Pde-Iv Inhibiting Activity
Patent: 6,476,025 →
Application: 09/889,144 →
Freeze-Dried Pantoprazole Preparation and Pantoprazole Injection
Patent: 6,780,881 →
Application: 10/195,062 →
Publication: US US20030003058A1
Novel Use of Pulmonary Surfactant
Patent: 6,982,075 →
Application: 10/491,961 →
Publication: US US20040247529A1
Surfactant Protein C Esters
Patent: 7,173,009 →
Application: 11/287,197 →
Publication: US US20060148701A1
Synergistic Combination Comprising Roflumilast and a Pde-3 Inhibitor
Patent: 6,897,229 →
Application: 10/286,915 →
Publication: US US20030050329A1
3-Cyclopropylmethoxy-4-Difluoromethoxy-N-(3,5-Dichloropyrid-4-Yl)Benzamide in the Treatment of Multiple Sclerosis
Patent: 6,531,493 →
Application: 09/914,763 →
Rapidly Disintegrating Tablet Comprising an Acid-Labile Active Ingredient
Patent: 7,147,869 →
Application: 10/433,397 →
Publication: US US20040110661A1
Composition Comprising a Pulmonary Surfactant and a PDE5 Inhibitor for the Treatment of Lung Diseases
Patent: 7,238,664 →
Application: 10/560,116 →
Publication: US US20060148693A1
Surfactant Protein C Esters
Patent: 7,022,671 →
Application: 09/959,628 →
Synergistic Combination Comprising Roflumilast and a Pde-3 Inhibitor
Patent: 6,498,173 →
Application: 09/959,599 →
New Pregna-1,4-DIENE3,20-Dione-16-17-Acetal-21 Esters, Process for Their Preparation, Composition, and Methods for the Treatment of Inflammatory Conditions
Patent: 5,482,934 →
Application: 08/278,112 →
Pharmaceutical Preparation Comprising an Active Dispersed on a Matrix
Patent: 7,175,854 →
Application: 10/433,398 →
Publication: US US20040058896A1
Synergistic Combination
Patent: 6,624,181 →
Application: 10/049,999 →
Recombinant Sp-a for the Treatment or Prevention of Pulmonary Infection and Inflammation
Patent: 7,135,452 →
Application: 09/889,348 →
Blind Clinical Trial Device
Patent: 6,544,250 →
Application: 09/830,427 →
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 25, 2002
From: LINDER, RUDOLF; DIETRICH, RANGO
To: ALTANA PHARMA AG
Reel/Frame 013425/0992 →
Change of Name Mar 26, 2013
From: NYCOMED GMBH
To: TAKEDA GMBH
Reel/Frame 030091/0737 →
Merger Jul 28, 2015
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 036201/0261 →
Merger Jul 28, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036193/0178 →
Change of Name Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0192 →
Merger Feb 15, 2016
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 037820/0324 →
Merger Feb 15, 2016
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 037820/0360 →
Change of Name Feb 15, 2016
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 038020/0258 →
Assignment of Assignor's Interest Jan 11, 2017
From: TAKEDA GMBH
To: ASTRAZENECA AB
Reel/Frame 041328/0362 →
Assignment of Assignor's Interest Apr 17, 2017
From: TAKEDA GMBH
To: FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
Reel/Frame 042030/0371 →
Assignment of Assignor's Interest Dec 10, 2018
From: ASTRAZENECA AB
To: COVIS PHARMA B.V.
Reel/Frame 047761/0435 →
Security Interest Dec 20, 2018
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 047834/0926 →
Security Interest Mar 12, 2020
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 052095/0262 →
Release of Security Interest Mar 17, 2020
From: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA B.V.
Reel/Frame 052142/0961 →
Business Transfer and Contribution Agreement Dec 16, 2020
From: COVIS PHARMA B.V.
To: COVIS PHARMA GMBH
Reel/Frame 054793/0416 →
Security Interest Feb 22, 2021
From: COVIS PHARMA GMBH
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 055354/0063 →
Release of Security Interest Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA GMBH
Reel/Frame 059043/0226 →
Release of Security Interest Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA B.V.
Reel/Frame 059043/0239 →